findmyKOL
Clinical trialNCT04237623RecruitingPhase 2Interventional

GM-CSF With Post-Transplant Cyclophosphamide

SponsorNorthside Hospital, Inc.Enrollment38Transplant-Related Hematologic Malignancy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Northside Hospital

    Atlanta, Georgia, United States

    Asad Bashey, MDH. Kent Holland, MDLawrence E Morris, MDMelhem Solh, MDScott Solomon, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 May 2020
Primary completion
18 Sept 2026
Completion
18 Sept 2026
Last update posted
16 Apr 2026
Registered enrollment
38
Registry id
NCT04237623
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.